药学监护研究进展

中国临床药理学与治疗学 ›› 2005, Vol. 10 ›› Issue (1): 1-4.

• 综述 • 下一篇

药学监护研究进展

师少军, 陈华庭, 曾繁典¹

华中科技大学同济医学院附属协和医院药剂科, 武汉 430022, 湖北;
¹临床药理研究所, 武汉 430030, 湖北

收稿日期:2004-11-09 修回日期:2004-12-29 出版日期:2005-01-26 发布日期:2020-11-19
通讯作者: 师少军, 男, 博士研究生, 主要从事临床药理和心血管药理研究。Tel:027-85726073 E-mail:sjshicn@163.com

Progress in research of pharmaceutical care

SHI Shao-jun, CHEN Hua-ting, ZENG Fan-dian¹

Department of Pharmacy of Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430022, Hubei, China;
¹Institute of Clinical Pharmacology, Wuhan 430030, Hubei, China

Received:2004-11-09 Revised:2004-12-29 Online:2005-01-26 Published:2020-11-19

摘要/Abstract

摘要： 21 世纪药师的基本任务就是实施药学监护,它是满足社会需要、医生需要和患者需要的必然产物。药学监护要求药师对其所进行的药物治疗负直接责任, 因此全面理解和提高药师提供药学监护的意识非常关键。本文重点论述了药学监护的内涵和临床应用, 并对其发展前景做出展望。

关键词: 药师, 医院药学, 药学监护, 临床药学

Abstract: Implementation of pharmaceutical care is the basic mission for the pharmacist in the 21st century. It is the necessary product for the need of the society, physician and patient.The practice of pharmaceutical care requires that pharmacists take responsibility for the outcomes of drug therapy.Therefore, it is significant to understand and raise pharmacist's awareness of providing pharmaceutical care services at all levels.This article reviewed the connotation and clinical application of pharmaceutical and predicted its prospect of development.

Key words: pharmacist, hospital pharmacy, pharmaceutical care, clinical pharmacy

中图分类号:

R952

师少军, 陈华庭, 曾繁典. 药学监护研究进展[J]. 中国临床药理学与治疗学, 2005, 10(1): 1-4.

SHI Shao-jun, CHEN Hua-ting, ZENG Fan-dian. Progress in research of pharmaceutical care[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(1): 1-4.

参考文献

1 Berenguer B, La Casa C, de la Matta MJ, Martin-Calero MJ. Pharmaceutical care:past, present and future[J].Curr Pharm Des, 2004;10:3931-46
2 Hepler CD, Strand LM.Opportunities and responsibilities in pharmaceutical care[J].Am J Hosp Pharm, 1990;47:533-43
3 American society of hospital pharmacists.ASHP statement on pharmaceutical care[J].Am J Hosp Pharm, 1993;50:1720-3
4 Cipolle RJ, Strand LM, Morley PC.Pharmceutical care practice [J].Minneapolis:McGraw Hill, NY, 1998;1:13
5 Ernst FR, Grizzle AJ.Drug related morbidity and mortality:updating the cost-of-illness model[J].J Am Pharm Assoc, 2001; 41:156-7
6 Lassetter JH, Warnick ML.Medical errors, drug-related problems, and medication errors:a literature review on quality of care and cost issues[J].J Nurs Care Qual, 2003;18:175-81
7 Bosso JA.Clinical pharmacy and pharmaceutical care [J]. Pharmacotherapy, 2004;24:1499-500
8 American society of health-system pharmacists.ASHP guidelines on a standardized method for pharmaceutical care[J].Am J Health Syst Pharm, 1996;53:1713-6
9 Canaday BR, Yarborough PC.Documenting pharmaceutical care:creating a standard[J].Ann Pharmacother, 1994;28: 1292-6
10 Sorensen TD, Biebighauser SM.Pharmaceutical care leadership:an innovative pharmacy practice residency model[J].J Am Pharm Assoc (Wash DC), 2003;43:527-32
11 Crealey GE, Sturgess IK, McElnay JC, Hughes CM.Pharmaceutical care programmes for the elderly:economic issues[J]. Pharmacoeconomics, 2003;21:455-65
12 Aparasu RR.The quality of pharmaceutical care in the elderly [J].S D J Med, 2004;57:489-90
13 Fischer LR, Defor TA, Cooper S, Scott LM, Boonstra DM, Eelkema MA, et al.Pharmaceutical care and health care utilization in an HMO[J].Eff Clin Pract, 2002;5:49-57
14 Chabot I, Moisan J, Gregoire JP, Milot A.Pharmacist intervention program for control of hypertension[J].Ann Pharmacother, 2003;37:1186-93
15 Larson LN, Rovers JP, MacKeigan LD.Patient satisfaction with pharmaceutical care:update of a validated instrument[J].J Am Pharm Assoc, 2002;42:44-50
16 Rossing C, Hansen EH, Krass I.The provision of pharmaceutical care in Denmark:a cross-sectional survey[J].J Clin Pharm Ther, 2003;28:311-8
17 Reeder CE, Kozma CM, O'Malley C.ASHP national survey of ambulatory care responsibilities of pharmacists in integrated health system[J].Am J Health Syst Pharm, 1998;55:35-43
18 Cipolle RJ.Experiences in pharmaceutical care[J].Pharmaceutic J, 2000;264:627-32
19 Dent LA, Stratton TP, Cochran GA.Establishing an on-site pharmacy in a community health center to help indigent patients access medications and to improve care[J].J Am Pharm Assoc, 2002;42:497-507
20 Carter BL.Implementing the new guidelines for hypertension: JNC7, ADA, WHO-ISH[J].J Manag Care Pharm, 2004;10: S18-25
21 Simpson SH, Johnson JA, Biggs RS, Tsuyuki RT, SCRIP investigators. Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus:a planned subgroup analysis of the study of cardiovascular risk intervention by pharmacists (SCRIP)[J].Pharmacotherapy, 2004;24:389-94
22 Liekweg A, WestfeldM, Jaehde U.From oncology pharmacy to pharmaceutical care:new contributions to multidisciplinary cancer care[J].Support Care Cancer, 2004;12:73-9
23 Gonzalez-Martin G, Joo I, Sanchez I.Evaluation of the impact of a pharmaceutical care program in children with asthma[J]. Patient Educ Couns, 2003;49:13-8
24 Wermeille J, Bennie M, Brown I, McKnight J.Pharmaceutical care model for patients with type 2 diabetes:integration of the community pharmacist into the diabetes team-a pilot study[J]. Pharm World Sci, 2004;26:18-25
25 Dunlop JA, Shaw JP.Community pharmacists perspectives on pharmaceutical care implementation in New Zealand[J].Pharm World Sci, 2002;24:224-30
26 Martin-Calero MJ, Machuca M, Murillo MD, Cansino J, Gastelurrutia MA, Faus MJ.Structural process and implementation programs of pharmaceutical care in different countries[J]. Curr Pharm Des, 2004;10:3969-85
27 Bennett MS, Blank D, Bopp J, James JA, Osterhaus MC. Strategies to improve compensation for pharmaceutical care services[J].J Am Pharm Assoc, 2000;40:747-55
28 Strand LM, Cipolle RJ, Morley PC, FrakesMJ.The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting:twenty-five years of experience[J].Curr Pharm Des, 2004;10:3987-4001

[1]	刘秀梅, 郭倩倩, 方圆, 陈楠, 齐琦. 经颈静脉肝内门体分流术后患者抗栓治疗的药学监护实践[J]. 中国临床药理学与治疗学, 2023, 28(5): 556-560.
[2]	张照伟, 李佐军, 黄坚, 李霜青, 何依玲. 临床药师在肾内科开展药学服务工作切入点的探索[J]. 中国临床药理学与治疗学, 2023, 28(2): 184-188.
[3]	俞亚红, 宋昱. 左心室辅助装置植入患者的药物治疗[J]. 中国临床药理学与治疗学, 2023, 28(2): 198-204.
[4]	周海辉张海霞葛卫红. 临床药师在癌痛规范化病房中的作用分析[J]. 中国临床药理学与治疗学, 2020, 25(9): 1038-1042.
[5]	杨瑞，刘慧，陈泽姮，戚听听，张赞玲，屈强. 临床药师基于CYP2C19基因检测指导氯吡格雷个体化用药及其疗效评价[J]. 中国临床药理学与治疗学, 2019, 24(8): 938-943.
[6]	羊波，石大伟，郑造乾. 一例血凝酶制剂致低纤维蛋白原血症患者的药学监护[J]. 中国临床药理学与治疗学, 2018, 23(8): 932-936.
[7]	袁玉梅，汪荣华，杨水新. 临床药师在他汀类药物引起的横纹肌溶解症中的药学服务[J]. 中国临床药理学与治疗学, 2018, 23(6): 704-708.
[8]	李静静，虞燕霞，唐莲，张金坤，余强，尚尔宁. 临床药学服务对幽门螺杆菌阳性消化性溃疡患者用药依从性及治疗效果的影响分析[J]. 中国临床药理学与治疗学, 2018, 23(2): 199-204.
[9]	朱旭婷，杭永付. 临床药师在肾内科的药学监护与实践[J]. 中国临床药理学与治疗学, 2018, 23(10): 1174-1178.
[10]	李楠，黄海涛，雍小兰. 1例误诊为中间葡萄球菌肺部感染的药学监护[J]. 中国临床药理学与治疗学, 2017, 22(9): 1067-1071.
[11]	党翔吉，周玲，王艺璇，曾露. 1例慢性肾功能不全患者个体化抗栓药物治疗实践[J]. 中国临床药理学与治疗学, 2017, 22(4): 477-480.
[12]	于洋，何佳珂，熊爱珍，丁楠. 前交叉韧带重建术后患者感染治疗方案的选择与个体化用药的思考[J]. 中国临床药理学与治疗学, 2017, 22(2): 194-197.
[13]	李敏，林晓贞，郑芝欣. 1例肾细胞癌服用舒尼替尼患者的药学监护[J]. 中国临床药理学与治疗学, 2016, 21(5): 538-542.
[14]	冯朴琼，林玮玮，张峻，王长连，焦正. 基于决策树模型的丙戊酸血药浓度解读及实践[J]. 中国临床药理学与治疗学, 2016, 21(12): 1425-1428.
[15]	谢悦良，刘晶晶，吴翠芳，陈莉，刘世坤. 耐碳青霉烯类-炎克雷伯菌肺部感染伴肾清除率增加患者的药学监护[J]. 中国临床药理学与治疗学, 2016, 21(10): 1149-1154.

药学监护研究进展

Progress in research of pharmaceutical care

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价